Inhibition of PCSK9 in familial hypercholesterolaemia
- PMID: 22633823
- DOI: 10.1016/S0140-6736(12)60814-9
Inhibition of PCSK9 in familial hypercholesterolaemia
Comment on
-
Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial.Lancet. 2012 Jul 7;380(9836):29-36. doi: 10.1016/S0140-6736(12)60771-5. Epub 2012 May 26. Lancet. 2012. PMID: 22633824 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
